| Name | DPM-1001 |
|---|
| Description | DPM-1001 is a potent, specific, orally bioavailable and non-competitive inhibitor of protein-tyrosine phosphatase (PTP1B) with an IC50 of 100 nM, an an analog of the specific PTP1B inhibitor trodusquemine (MSI-1436; IC50=600 nM). DPM-1001 has anti-diabetic property[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 100 nM (PTP1B)[1] |
| References |
| Molecular Formula | C35H57N3O3 |
|---|---|
| Molecular Weight | 567.85 |